RGEN

RGEN

USD

Repligen Corporation Common Stock

$146.930-2.130 (-1.429%)

Echtzeitkurs

Healthcare
Medical Instruments & Supplies
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$149.060

Hoch

$151.250

Tief

$146.000

Volumen

0.61M

Unternehmensfundamentaldaten

Marktkapitalisierung

8.3B

Branche

Medical Instruments & Supplies

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.92M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $102.97Aktuell $146.930Hoch $182.52

Ähnliche Nachrichten

GlobeNewswire

Repligen Corporation to Present at Upcoming November Conferences

WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming

Mehr anzeigen
Repligen Corporation to Present at Upcoming November Conferences
Analyst Upgrades

Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $165

Canaccord Genuity analyst Kyle Mikson maintains Repligen with a Hold and raises the price target from $150 to $165.

Mehr anzeigen
Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $165
Analyst Upgrades

Barclays Maintains Overweight on Repligen, Raises Price Target to $175

Barclays analyst Luke Sergott maintains Repligen with a Overweight and raises the price target from $160 to $175.

Mehr anzeigen
Barclays Maintains Overweight on Repligen, Raises Price Target to $175
GlobeNewswire

Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchisesOrders increased sequentially and greater than 20% year-over-yearIncreasing

Mehr anzeigen
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
GlobeNewswire

Repligen to Report Third Quarter 2025 Financial Results

WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial results on Tuesday, October 28, 2025. The Company will

Mehr anzeigen
Repligen to Report Third Quarter 2025 Financial Results